WIN-63480-2

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWIN-63480-2
Drug Alias NameWin 63480WIN-63480-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsEpilepsyAlzheimer DiseaseStroke +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSterling Winthrop Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSterling Winthrop Inc
Active IndicationsN/A
Inactive IndicationsEpilepsyAlzheimer DiseaseStroke +[4] 

Other Information

ATC CodeN/A
Related LinksN/A